Question 1

What’s the financial overview for Virpax Pharmaceuticals, Inc.?

Accepted Answer

Virpax Pharmaceuticals, Inc.’s market cap stands at $0.00 trillion right now. The company’s trailing twelve-month earnings per share EPS is $-71.00, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Virpax Pharmaceuticals, Inc. Stock ROE tell us?

Accepted Answer

Virpax Pharmaceuticals, Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for Virpax Pharmaceuticals, Inc.?

Accepted Answer

The Virpax Pharmaceuticals, Inc. stock per share price is $0.02.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$0.00	$0.00	$0.00	$0.00
Gross Profit	$0.00	$0.00	$0.00	$0.00
Gross Profit Ratio	$0.00	$0.00	$0.00	$0.00
R&D Expenses	$1.11M	$1.14M	$1.96M	$1.61M
SG&A Expenses	$2.29M	$780958.00	$1.50M	$1.69M
Operating Expenses	$3.39M	$1.92M	$3.46M	$3.30M
Total Costs & Expenses	$3.39M	$1.92M	$3.46M	$3.30M
Interest Income	$0.00	$0.00	$0.00	$0.00
Interest Expense	$0.00	$92748.00	$11000.00	$0.00
Depreciation & Amortization	$0.00	$10650.00	$19128.00	$3.30M
EBITDA	-$3.39M	-$1.91M	-$3.46M	-$3.30M
EBITDA Ratio
Operating Income	-$3.39M	-$1.92M	-$3.46M	-$3.30M
Operating Income Ratio
Other Income/Expenses (Net)	$4654.00	-$82102.00	$8126.00	$82033.00
Income Before Tax	-$3.39M	-$2.006M	-$3.45M	-$3.22M
Income Before Tax Ratio
Income Tax Expense	$0.00	$0.00	$0.00	-$3.30M
Net Income	-$3.39M	-$2.006M	-$3.45M	-$3.22M
Net Income Ratio
EPS	-$0.80	-$0.43	-$1.75	-$2.75
Diluted EPS	-$0.80	-$0.43	-$1.75	-$2.75
Weighted Avg Shares Outstanding	$4.25M	$4.66M	$1.98M	$1.17M
Weighted Avg Shares Outstanding (Diluted)	$4.25M	$4.66M	$1.98M	$1.17M

Virpax Pharmaceuticals, Inc.